Small Caps News
Creo Medical ends year with revenue above forecasts
Surgical endoscopy medical device company Creo Medical Group said it continued to deliver on its three-tiered 'build, buy and partner' strategy in a trading update on Thursday, saying it built momentum through “sustained commercial progress” in 2021.
Seeen revenue falls as it narrows EBITDA loss
Video optimisation technology company Seeen said in a trading update on Thursday that its revenue in 2021 was $8. 5m, down from $10. 1m in 2020, reflecting changes it made to improve the quality and profitability of its customer base, and the sales contribution from its video technology products and services.
Omega gets CE-marking for Covid-19 test, working on UK approval
Medical diagnostics specialist Omega has successfully CE-marked its ‘Visitect’ Covid-19 antigen test for self-test use, it announced on Thursday.
Rambler raises £3.8m for underground development work
Copper and gold explorer, producer and developer Rambler Metals and Mining has raised £3. 83m, it announced on Thursday, to help fund its underground development.
Dillistone ends year in line with market expectations
Recruitment software supplier Dillistone updated the market on its trading for 2021 on Thursday, reporting further improvements in the fourth quarter, with incoming orders at levels “not seen for a number of years”.
Verditek offloads stake in ICSI to Baker Hughes Canada
Solar technology company Verditek announced the completion of the sale of Industrial Climate Solutions (ICSI) on Thursday, in which it held a 10. 56% stake, to Baker Hughes Energy Services Canada.
Crimson Tide losses 'slightly smaller' than expected
Mobility technology and software company Crimson Tide said in a trading update on Thursday that revenue in 2021 was “slightly ahead” of expectations of £4m.
Afentra continues discussions over acquiring Angola blocks
Afentra confirmed on Thursday that negotiations with Sonangol to purchase interests in block 3/05 and block 23 in Angola had continued into the new year.
Avacta moves to next dose in first-in-human chemotherapy trial
Clinical-stage oncology drug company Avacta announced on Thursday that the first-in-human phase 1 trial of ‘AVA6000’ pro-doxorubicin would advance to the next dose cohort, following a positive review of the safety data from the dosing of the first cohort.
Atalaya Mining pleased with latest drilling at PMV
Atalaya Mining announced the results of five additional drill holes from its ongoing resource definition drilling programme at Proyecto Masa Valverde (PMV) in southern Spain on Thursday.
CMA issues £35m in fines for illegal anti-nausea tablet supply arrangement
The Competition and Markets Authority has fined several pharmaceutical and private equity firms over £35. 0m for an illegal arrangement in the supply of important NHS prescription anti-nausea tablets.
ScS Group order intake grows in H1
Furniture and flooring retailer ScS Group said on Thursday that it traded well through the important winter sale period and that order intake for the first half of the year was in line with internal expectations.
Virgin Wines FY profit to miss expectations, shares slide
Virgin Wines posted a jump in first-half revenue on Thursday but warned that revenue and profit for the year would be below expectations due to the uncertain trading and macro environment and increased cost pressures.